227 findings · Adherence · published 2025+
- AdherenceLimited
At a population level, distributing GLP-1 medications using extended dosing intervals (q2wk) allows twice as many obese adults to be treated for the same total cost, leading to greater reductions in national obesity rates and mortality.
For policymakers and insurers, extending GLP-1 dosing intervals to every two weeks allows the same budget to treat twice as many people. While each individual might lose slightly less weight, the overall public health benefit (reduced obesity and mortality) is significantly higher. This is a key strategy for making these drugs accessible at a national scale.
Supports 2025New - AdherenceLimited
The Blue Zones longevity paradigm is invalid because extreme longevity records in these regions are statistically associated with poverty, illiteracy, and clerical errors rather than lifestyle factors.
Do not rely on Blue Zone recommendations as a guaranteed path to longevity. The evidence suggests that the extreme longevity often cited in these regions is likely due to administrative errors and fraud rather than their lifestyle. Focus on verifiable health metrics and accurate data rather than geographic myths.
Refutes 2025New - AdherenceLimited
Metabolic and bariatric surgery (MBS) slightly increases the risk of substance use disorders and suicide deaths more than 2 years post-surgery compared to nonsurgical controls.
Be aware that while MBS improves mental health symptoms, it may slightly increase the risk of substance use disorders and suicide more than 2 years after surgery. Long-term mental health support and monitoring are essential to mitigate these risks.
Refutes 2025New - AdherenceLimited
An automatic remote weight management system using smart scales and cloud-based dashboards can effectively monitor treatment response and identify early deviations from weight trajectories without increasing patient burden.
Using a smart scale that automatically uploads data to your doctor's dashboard can help catch weight regain early without you having to do extra work. This tool helps your care team prioritize who needs help, potentially keeping you on your medication and avoiding unnecessary visits.
Supports 2025New - AdherenceLimited
GLP-1 RAs are associated with an increased risk of suicidal behavior and self-harm, particularly in patients with underlying mental health vulnerabilities or dysphoria.
If you are taking Semaglutide and experience mood changes, depression, or suicidal thoughts, contact your healthcare provider immediately. Do not ignore these symptoms. Regular screening for mental health is recommended for all patients on this medication.
Qualifies 2025New - AdherenceWeak
A multidisciplinary group intervention combining nutritional education, physical activity, and emotional management promotes sustainable weight loss (5-10%) and improves quality of life in adults with obesity.
To manage obesity effectively, consider joining a structured group program that combines nutrition education, physical activity, and emotional support. Look for programs that meet weekly for about two months and include follow-up visits. The social aspect and focus on emotional well-being can help you stick to healthy habits long-term.
Supports 2025New - AdherenceWeak
Implementing a structured, EHR-driven care process (PATHWEIGH) in primary care mitigates population-level weight gain and increases the likelihood of patients receiving weight-related care, even among those who do not receive direct clinical intervention.
If you are a healthcare system, stop waiting for patients to ask for help. Use your electronic health records to flag patients with high BMI and prompt doctors to discuss weight. Educate your staff that obesity is a chronic disease, not a lifestyle failure. This simple process change can help patients lose weight even if they never see a specialist.
Supports 2025New - AdherenceWeak
Integrating intermittent Continuous Glucose Monitoring (CGM) with culturally-informed kaiāwhina support and optimized clinical care significantly reduces HbA1c levels in patients with Type 2 Diabetes compared to usual care.
For patients with Type 2 Diabetes who struggle with standard care, combining continuous glucose monitoring (CGM) with culturally tailored support (kaiāwhina) and optimized medical management can significantly improve blood sugar control. This approach addresses both the technical aspect of glucose tracking and the social/cultural barriers to care.
Supports 2025New - AdherenceWeak
A 36-month complex lifestyle intervention combining digital tools, face-to-face group education, and individual consultations significantly reduces the incidence of type 2 diabetes in adults with prediabetes compared to usual care.
If you have prediabetes, a structured program combining regular group education, personal coaching, and digital tracking over 3 years is designed to help you lose weight, eat healthier, and exercise more to prevent diabetes. This approach is more comprehensive than digital tools alone.
Supports 2026New - AdherenceWeak
A 1-year person-centered and culturally sensitive intervention, including continuous glucose monitoring and extended healthcare professional consultations, improves glycemic control (HbA1c) and diabetes management in non-Western, Arabic-, Turkish-, or Urdu-speaking individuals with Type 2 Diabetes compared to usual care.
For individuals with Type 2 Diabetes from Arabic, Turkish, or Urdu-speaking backgrounds, standard care may not be enough. This protocol suggests seeking a specialized, culturally sensitive program that includes continuous glucose monitoring, extended consultations with the same healthcare team, and education in your native language. This approach aims to improve blood sugar control and overall well-being by addressing language barriers and cultural needs.
Supports 2025New - AdherenceWeak
Cohabiting with a partner receiving tirzepatide pharmacotherapy can induce significant weight loss and metabolic improvement in an untreated spouse through vicarious efficacy driven by shared environmental and behavioral changes.
If you are starting tirzepatide and live with a partner who has metabolic issues, your changes to food shopping and cooking habits may significantly benefit them too. Encourage your partner to monitor their health metrics, as they may see improvements in weight and blood sugar without needing medication themselves. Discuss these changes openly to ensure both partners are comfortable with the household shifts.
Supports 2025New